QIAGEN is the leading global provider of sample to insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.
QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).
The QIAGEN business has grown in leaps and bounds in KSA, both in the government and private sectors. The Unit is operating in several fields related to research of life and medical sciences. We are proud to have played a key role in several mega projects during seasonal outbreaks for respiratory infections.
The Unit is well equipped with qualified and experienced staff who provide technical and scientific support to customers all over the Kingdom.
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing.